Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.48 |
| ▸ | CA6 | P23280 | 5/20 | 0.48 |
| ▸ | CA7 | P43166 | 5/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA4 | P22748 | 4/20 | 0.48 |
| ▸ | CA5A | P35218 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CASP2 | P42575 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19669 | 0.98 | CA12 (0.48) | CA12CA6CA7CA9CA14 | |
| SCHEMBL27591294 | 0.96 | CA12 (0.46) | CA12CA6CA7CA9CA14 | |
| SCHEMBL8984823 | 0.89 | CYP2C19 (0.35) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28735575 | 0.81 | TSHR (0.39) | CA12CA6CA7CA9CA14 | |
| SCHEMBL23327735 | 0.81 | ALDH1A1 (0.37) | LMNATDP1ALOX15ALDH1A1TP53 | |
| SCHEMBL28647993 | 0.80 | TSHR (0.40) | ALDH1A1MEN1KMT2ACYP1A2CYP2C19 | |
| SCHEMBL687065 | 0.80 | TSHR (0.46) | CA12CA7CA14CA2CA1 | |
| SCHEMBL31297376 | 0.79 | CA12 (0.52) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28097925 | 0.79 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL29048093 | 0.79 | CA12 (0.39) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352486-A1 | NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS | UNIVERSITAT POLITÈCNICA DE VALÈNCIA (ES) | 2025-11-20 | — | — | US | disclosed |
| EP-4529916-A1 | NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS | Universitat Politècnica de València (ES) | 2025-04-02 | — | — | EP | disclosed |
| EP-3286253-A1 | PROCESS FOR MODIFYING POLYMERS | Akzo Nobel Chemicals International B.V. (NL) | 2018-02-28 | — | — | EP | disclosed |
| US-20170165375-A1 | ANTIBIOTIC PROTOCELLS AND RELATED PHARMACEUTICAL FORMULATIONS AND METHODS OF TREATMENT | SANDIA CORPORATION | 2017-06-15 | — | — | US | disclosed |
| WO-2016170018-A1 | PROCESS FOR MODIFYING POLYMERS | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2016-10-27 | — | — | WO | disclosed |
| WO-2015175850-A1 | RESIN-COATED SUBSTRATE COMPOSITIONS AND METHODS OF MAKING THE SAME | U.S. SILICA COMPANY (US) | 2015-11-19 | — | — | WO | disclosed |
| EP-1025145-A1 | MEANS AND METHODS FOR ENHANCING INTERFACIAL ADHESION BETWEEN A METAL SURFACE AND A NON-METALLIC MEDIUM AND PRODUCTS OBTAINED THEREBY | N.V. BEKAERT S.A. (BE) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999020682-A1 | MEANS AND METHODS FOR ENHANCING INTERFACIAL ADHESION BETWEEN A METAL SURFACE AND A NON-METALLIC MEDIUM AND PRODUCTS OBTAINED THEREBY | N.V. BEKAERT S.A. (BE) | 1999-04-29 | — | — | WO | disclosed |
| US-5698725-A | IMINE-CONTAINING ORGANOSILICON COMPOUND | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 1997-12-16 | — | — | US | disclosed |
| EP-0768313-A2 | A surface treating agent for glass fiber substrates | Dow Corning Toray Silicone Company Limited (JP) | 1997-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170165375-A1 | ANTIBIOTIC PROTOCELLS AND RELATED PHARMACEUTICAL FORMULATIONS AND METHODS OF TREATMENT | PHOSPHO1, LIPA, BCR | CA12 1591/4885CA6 1988/4885CA7 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.